1J9C - JenaLib

Asymmetric/Biological Unit (106, 106)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
001	UniProt	VAR_014298	T	36	A	TF_HUMAN	Polymorphism	3917604	T	T	4	A
002	UniProt	VAR_015138	G	216	D	FA7_HUMAN	Disease (FA7D)	---	H	G	19	D
003	UniProt	VAR_006506	C	238	Y	FA7_HUMAN	Disease (FA7D)	121964928	H	C	42	Y
004	UniProt	VAR_065387	G	240	R	FA7_HUMAN	Disease (FA7D)	---	H	G	44	R
005	UniProt	VAR_014413	T	241	N	FA7_HUMAN	Disease (FA7D)	---	H	T	45	N
006	UniProt	VAR_065388	S	250	F	FA7_HUMAN	Disease (FA7D)	---	H	S	54	F
007	UniProt	VAR_065389	A	251	P	FA7_HUMAN	Disease (FA7D)	---	H	A	55	P
008	UniProt	VAR_065390	A	251	T	FA7_HUMAN	Disease (FA7D)	---	H	A	55	T
009	UniProt	VAR_065376	N	117	D	FA7_HUMAN	Disease (FA7D)	121964932	L	N	57	D
010	UniProt	VAR_065391	C	254	R	FA7_HUMAN	Disease (FA7D)	---	H	C	58	R
011	UniProt	VAR_015139	C	254	Y	FA7_HUMAN	Disease (FA7D)	---	H	C	58	Y
012	UniProt	VAR_015136	S	120	P	FA7_HUMAN	Disease (FA7D)	---	L	S	60	P
013	UniProt	VAR_014407	C	121	F	FA7_HUMAN	Disease (FA7D)	---	L	C	61	F
014	UniProt	VAR_065392	L	264	P	FA7_HUMAN	Disease (FA7D)	753266903	H	L	64	P
015	UniProt	VAR_014408	L	125	P	FA7_HUMAN	Disease (FA7D)	---	L	L	65	P
016	UniProt	VAR_015140	A	266	T	FA7_HUMAN	Disease (FA7D)	764807079	H	A	66	T
017	UniProt	VAR_014409	Y	128	C	FA7_HUMAN	Disease (FA7D)	---	L	Y	68	C
018	UniProt	VAR_065393	D	272	N	FA7_HUMAN	Disease (FA7D)	751028917	H	D	72	N
019	UniProt	VAR_065394	D	277	N	FA7_HUMAN	Disease (FA7D)	550074221	H	D	77	N
020	UniProt	VAR_065377	G	138	D	FA7_HUMAN	Disease (FA7D)	---	L	G	78	D
021	UniProt	VAR_006497	R	139	K	FA7_HUMAN	Disease (FA7D)	---	L	R	79	K
022	UniProt	VAR_006498	R	139	Q	FA7_HUMAN	Disease (FA7D)	150525536	L	R	79	Q
023	UniProt	VAR_006499	R	139	W	FA7_HUMAN	Disease (FA7D)	776796178	L	R	79	W
024	UniProt	VAR_006507	R	283	W	FA7_HUMAN	Disease (FA7D)	779589651	H	R	83	W
025	UniProt	VAR_014410	C	151	S	FA7_HUMAN	Disease (FA7D)	---	L	C	91	S
026	UniProt	VAR_015137	E	154	K	FA7_HUMAN	Disease (FA7D)	146795869	L	E	94	K
027	UniProt	VAR_013936	V	295	D	FA7_HUMAN	Polymorphism	6045	H	V	95	D
028	UniProt	VAR_065378	G	156	S	FA7_HUMAN	Disease (FA7D)	563972504	L	G	96	S
029	UniProt	VAR_006501	G	157	C	FA7_HUMAN	Disease (FA7D)	---	L	G	97	C
030	UniProt	VAR_006500	G	157	S	FA7_HUMAN	Disease (FA7D)	763458490	L	G	97	S
031	UniProt	VAR_014411	G	157	V	FA7_HUMAN	Disease (FA7D)	771335282	L	G	97	V
032	UniProt	VAR_065395	T	298	I	FA7_HUMAN	Disease (FA7D)	---	H	T	98	I
033	UniProt	VAR_006502	Q	160	R	FA7_HUMAN	Disease (FA7D)	200016360	L	Q	100	R
034	UniProt	VAR_065396	H	301	Q	FA7_HUMAN	Disease (FA7D)	---	H	H	101	Q
035	UniProt	VAR_014414	D	302	H	FA7_HUMAN	Disease (FA7D)	---	H	D	102	H
036	UniProt	VAR_014415	D	302	N	FA7_HUMAN	Disease (FA7D)	770328850	H	D	102	N
037	UniProt	VAR_014416	A	304	T	FA7_HUMAN	Disease (FA7D)	773627551	H	A	104	T
038	UniProt	VAR_006508	A	304	V	FA7_HUMAN	Disease (FA7D)	121964931	H	A	104	V
039	UniProt	VAR_014417	R	307	C	FA7_HUMAN	Disease (FA7D)	147680958	H	R	107	C
040	UniProt	VAR_006509	R	307	H	FA7_HUMAN	Disease (FA7D)	121964929	H	R	107	H
041	UniProt	VAR_065379	S	171	F	FA7_HUMAN	Disease (FA7D)	143855920	L	S	111	F
042	UniProt	VAR_015141	V	312	M	FA7_HUMAN	Disease (FA7D)	201991361	H	V	112	M
043	UniProt	VAR_014299	I	145	V	TF_HUMAN	Polymorphism	3917627	T	I	113	V
044	UniProt	VAR_065397	L	314	V	FA7_HUMAN	Disease (FA7D)	---	H	L	114	V
045	UniProt	VAR_065380	G	177	R	FA7_HUMAN	Disease (FA7D)	---	L	G	117	R
046	UniProt	VAR_065398	L	321	F	FA7_HUMAN	Disease (FA7D)	778138366	H	L	121	F
047	UniProt	VAR_065381	L	181	P	FA7_HUMAN	Disease (FA7D)	---	L	L	121	P
048	UniProt	VAR_065382	D	183	N	FA7_HUMAN	Disease (FA7D)	---	L	D	123	N
049	UniProt	VAR_065399	L	323	R	FA7_HUMAN	Disease (FA7D)	---	H	L	123	R
050	UniProt	VAR_006510	E	325	K	FA7_HUMAN	Disease (FA7D)	749760143	H	E	125	K
051	UniProt	VAR_065383	S	186	F	FA7_HUMAN	Disease (FA7D)	764971156	L	S	126	F
052	UniProt	VAR_065400	R	326	Q	FA7_HUMAN	Disease (FA7D)	146698837	H	R	126	Q
053	UniProt	VAR_065384	P	189	S	FA7_HUMAN	Disease (FA7D)	---	L	P	129	S
054	UniProt	VAR_012008	R	163	W	TF_HUMAN	Polymorphism	5901	T	R	131	W
055	UniProt	VAR_065401	R	337	C	FA7_HUMAN	Disease (FA7D)	139372641	H	R	134	C
056	UniProt	VAR_065385	P	194	L	FA7_HUMAN	Disease (FA7D)	---	L	P	134	L
057	UniProt	VAR_006503	P	194	T	FA7_HUMAN	Disease (FA7D)	---	L	P	134	T
058	UniProt	VAR_014412	C	195	R	FA7_HUMAN	Disease (FA7D)	372577568	L	C	135	R
059	UniProt	VAR_006504	K	197	E	FA7_HUMAN	Disease (FA7D)	---	L	K	137	E
060	UniProt	VAR_015142	V	341	F	FA7_HUMAN	Disease (FA7D)	---	H	V	138	F
061	UniProt	VAR_065386	I	198	T	FA7_HUMAN	Disease (FA7D)	762621913	L	I	138	T
062	UniProt	VAR_065402	G	343	S	FA7_HUMAN	Disease (FA7D)	---	H	G	140	S
063	UniProt	VAR_076570	W	344	G	FA7_HUMAN	Disease (FA7D)	---	H	W	141	G
064	UniProt	VAR_065403	W	344	R	FA7_HUMAN	Disease (FA7D)	---	H	W	141	R
065	UniProt	VAR_065404	G	345	S	FA7_HUMAN	Disease (FA7D)	---	H	G	142	S
066	UniProt	VAR_065405	R	350	C	FA7_HUMAN	Disease (FA7D)	747876824	H	R	147	C
067	UniProt	VAR_013122	A	352	T	FA7_HUMAN	Polymorphism	3093267	H	A	150	T
068	UniProt	VAR_006511	A	354	V	FA7_HUMAN	Disease (FA7D)	36209567	H	A	152	V
069	UniProt	VAR_006512	M	358	I	FA7_HUMAN	Disease (FA7D)	149283257	H	M	156	I
070	UniProt	VAR_006513	M	358	V	FA7_HUMAN	Disease (FA7D)	---	H	M	156	V
071	UniProt	VAR_065406	L	360	P	FA7_HUMAN	Disease (FA7D)	---	H	L	158	P
072	UniProt	VAR_065407	P	363	H	FA7_HUMAN	Disease (FA7D)	---	H	P	161	H
073	UniProt	VAR_015143	P	363	R	FA7_HUMAN	Disease (FA7D)	---	H	P	161	R
074	UniProt	VAR_006514	R	364	Q	FA7_HUMAN	Disease (FA7D)	121964926	H	R	162	Q
075	UniProt	VAR_065408	R	364	W	FA7_HUMAN	Disease (FA7D)	750980786	H	R	162	W
076	UniProt	VAR_018671	T	367	S	FA7_HUMAN	Polymorphism	747673406	H	T	165	S
077	UniProt	VAR_006515	C	370	F	FA7_HUMAN	Disease (FA7D)	121964927	H	C	168	F
078	UniProt	VAR_065410	T	384	M	FA7_HUMAN	Disease (FA7D)	531225271	H	T	177	M
079	UniProt	VAR_065411	M	387	T	FA7_HUMAN	Disease (FA7D)	---	H	M	180	T
080	UniProt	VAR_065412	M	387	V	FA7_HUMAN	Disease (FA7D)	---	H	M	180	V
081	UniProt	VAR_065413	F	388	S	FA7_HUMAN	Disease (FA7D)	121964938	H	F	181	S
082	UniProt	VAR_014392	C	389	G	FA7_HUMAN	Disease (FA7D)	121964934	H	C	182	G
083	UniProt	VAR_065415	D	398	E	FA7_HUMAN	Disease (FA7D)	---	H	D	189	E
084	UniProt	VAR_065416	K	401	E	FA7_HUMAN	Disease (FA7D)	748979195	H	K	192	E
085	UniProt	VAR_006517	G	402	E	FA7_HUMAN	Disease (FA7D)	---	H	G	193	E
086	UniProt	VAR_006516	G	402	R	FA7_HUMAN	Disease (FA7D)	---	H	G	193	R
087	UniProt	VAR_015144	D	403	H	FA7_HUMAN	Disease (FA7D)	---	H	D	194	H
088	UniProt	VAR_065417	S	404	N	FA7_HUMAN	Disease (FA7D)	---	H	S	195	N
089	UniProt	VAR_065418	H	408	Q	FA7_HUMAN	Disease (FA7D)	121964936	H	H	199	Q
090	UniProt	VAR_065419	H	408	R	FA7_HUMAN	Disease (FA7D)	---	H	H	199	R
091	UniProt	VAR_065420	R	413	G	FA7_HUMAN	Disease (FA7D)	---	H	R	204	G
092	UniProt	VAR_006518	R	413	Q	FA7_HUMAN	Polymorphism	6046	H	R	204	Q
093	UniProt	VAR_065421	G	414	C	FA7_HUMAN	Disease (FA7D)	121964937	H	G	205	C
094	UniProt	VAR_006519	T	419	M	FA7_HUMAN	Disease (FA7D)	121964930	H	T	210	M
095	UniProt	VAR_065422	V	422	F	FA7_HUMAN	Disease (FA7D)	---	H	V	213	F
096	UniProt	VAR_065423	G	425	A	FA7_HUMAN	Disease (FA7D)	---	H	G	216	A
097	UniProt	VAR_065424	G	425	C	FA7_HUMAN	Disease (FA7D)	---	H	G	216	C
098	UniProt	VAR_065426	G	432	D	FA7_HUMAN	Disease (FA7D)	---	H	G	223	D
099	UniProt	VAR_014420	G	435	E	FA7_HUMAN	Disease (FA7D)	756956471	H	G	226	E
100	UniProt	VAR_065427	Y	437	F	FA7_HUMAN	Disease (FA7D)	758213652	H	Y	228	F
101	UniProt	VAR_013123	E	445	K	FA7_HUMAN	Polymorphism	3093248	H	E	236	K
102	UniProt	VAR_014418	T	332	M	FA7_HUMAN	Disease (FA7D)	200212201	H	T	129C	M
103	UniProt	VAR_065409	R	375	W	FA7_HUMAN	Disease (FA7D)	137919286	H	R	170C	W
104	UniProt	VAR_065414	G	391	C	FA7_HUMAN	Disease (FA7D)	---	H	G	184A	C
105	UniProt	VAR_014419	G	391	S	FA7_HUMAN	Disease (FA7D)	190485816	H	G	184A	S
106	UniProt	VAR_065425	A	429	T	FA7_HUMAN	Disease (FA7D)	755377592	H	A	221A	T

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

PROSITE Motifs (7, 7)

Exons (10, 11)

Sequences/Alignments

Asymmetric/Biological Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain H from PDB  Type:PROTEIN  Length:254
 aligned with FA7_HUMAN | P08709 from UniProtKB/Swiss-Prot  Length:466

    Alignment length:254
                                   222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462    
           FA7_HUMAN    213 IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP  466
               SCOP domains d1j9ch_ H: Coagulation factor VIIa                                                                                                                                                                                                                             SCOP domains
               CATH domains 1j9cH01     1j9cH02 H:28-120,H:233-246 Trypsin-like serine proteases                                        1j9cH01 H:16-27,H:121-232 Trypsin-like serine proteases                                                                  1j9cH02       ----------- CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ....ee........eeeeee..eeeeeeeeee..eeeehhhhhh.......eeeee............eeeeeeeee..............eeeee................hhhhhhhhhhhh.eeeeee..............eeeeeeeehhhhhhhhh............eeee................eeeeee..eeeeeeeeeee.........eeeee...hhhhhhhhhhh......ee..... Sec.struct. author
             SAPs(SNPs) (1) ---D---------------------Y-RN--------FP--R---------P-T-----N----N-----W-----------D--I--QH-T--C----M-V------F-R-KQ-----M----C---F-SGS----C-T-V---I-P--HQ--S--F----W--------M--TSG-C------E--EEHN---Q----GC----M--F--A---T--D--E-F-------K--------------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) --------------------------------------T--Y-----------------------------------------------N-V--H------------------------------------R-------------V----RW----------------------V---S----------R-----R----Q-----------C----------------------------------------- SAPs(SNPs) (2)
                PROSITE (1) TRYPSIN_DOM  PDB: H:16-243 UniProt: 213-452                                                                                                                                                                                                     -------------- PROSITE (1)
                PROSITE (2) ------------------------------------TRYPSI-----------------------------------------------------------------------------------------------------------------------------------------------TRYPSIN_SER --------------------------------------------------------- PROSITE (2)
           Transcript 2 (1) Exon 2.8c      -----------------------------------------Exon 2.10b  PDB: H:69-257 (gaps) UniProt: 269-466                                                                                                                                                      Transcript 2 (1)
           Transcript 2 (2) ---------------Exon 2.9  PDB: H:31-69 (gaps)             ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript 2 (2)
                1j9c H   16 IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP  257
                                    25        35|       46        56    ||||62        72        82        92       102       112       122      129C|||||  139       150       160       170|||||||175       184   |   193       203       213   || |223       233       243       253    
                                              35|                     60A|||                                                                  129A|||||||          147|                  170A||||||175     184A 188A                           217| |                                     
                                               37                      60B||                                                                   129B||||||           149                   170B|||||||                                           219 |                                     
                                                                        60C|                                                                    129C|||||                                  170C||||||                                            221A                                     
                                                                         60D                                                                     129D||||                                   170D|||||                                                                                     
                                                                                                                                                  129E|||                                    170E||||                                                                                     
                                                                                                                                                   129F||                                     170F|||                                                                                     
                                                                                                                                                    129G|                                      170G||                                                                                     
                                                                                                                                                      134                                       170H|                                                                                     
                                                                                                                                                                                                 170I

Chain L from PDB  Type:PROTEIN  Length:95
 aligned with FA7_HUMAN | P08709 from UniProtKB/Swiss-Prot  Length:466

    Alignment length:95
                                   117       127       137       147       157       167       177       187       197     
           FA7_HUMAN    108 DQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDDQLICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILE  202
               SCOP domains d1j9cl1 L:48-86 Coagulation factor VIIad1j9cl2 L:87-142 Coagulation factor VIIa                 SCOP domains
               CATH domains 1j9cL01 L:48-88 Laminin                  1j9cL02 L:89-142 Laminin                               CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .hhhhh......................ee.....ee.........hhhhh..eeeee..eeeeee....eee......eee............. Sec.struct. author
             SAPs(SNPs) (1) ---------D--PF---P--C---------DK-----------S--K-SC--R----------F-----R---P-N--F--S----LR-ET---- SAPs(SNPs) (1)
             SAPs(SNPs) (2) -------------------------------Q-----------------S------------------------------------T-------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) -------------------------------W-----------------V--------------------------------------------- SAPs(SNPs) (3)
                PROSITE (1) -------------ASX_HYDROXYL---------------------------------------EGF_2           --------------- PROSITE (1)
                PROSITE (2) ----------------------EGF_1       ------------------------------------------------------------- PROSITE (2)
           Transcript 2 (1) Exon 2.4c  PDB: L:48-84 [INCOMPLETE] ----------------------------------------------Exon 2.8c    Transcript 2 (1)
           Transcript 2 (2) ------------------------------------Exon 2.7  PDB: L:84-131 UniProt: 144-191        ----------- Transcript 2 (2)
                1j9c L   48 DQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDDQLICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILE  142
                                    57        67        77        87        97       107       117       127       137

Chain T from PDB  Type:PROTEIN  Length:210
 aligned with TF_HUMAN | P13726 from UniProtKB/Swiss-Prot  Length:295

    Alignment length:210
                                    42        52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242
            TF_HUMAN     33 SGTTNTVAAYNLTWKSTNFKTILEWEPKPVNQVYTVQISTKSGDWKSKCFYTTDTECDLTDEIVKDVKQTYLARVFSYPAGNVESTGSAGEPLYENSPEFTPYLETNLGQPTIQSFEQVGTKVNVTVEDERTLVRRNNTFLSLRDVFGKDLIYTLYYWKSSSSGKKTAKTNTNEFLIDVDKGENYCFSVQAVIPSRTVNRKSTDSPVECM  242
               SCOP domains d1j9ct1 T:1-106 Extracellular region of human tissue factor                                               d1j9ct2 T:107-210 Extracellular region of human tissue factor                                            SCOP domains
               CATH domains --1j9cT01 T:3-105 Immunoglobulins                                                                        1j9cT02 T:106-210 Immunoglobulins                                                                         CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author .........eeeeeeee..eeeeeee.....eeeeeeeee.....eeeeeee...eeehhhhhhhhh...eeeeeeeee.............eeee....hhhhhh..........ee...eee......eeeeee..eeeehhhhh....eeeeee........eee........ee.........eeeee.................. Sec.struct. author
                 SAPs(SNPs) ---A------------------------------------------------------------------------------------------------------------V-----------------W------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE --------------------------------------------TISSUE_FACTOR     ---------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) 1.------------------------------------Exon 1.4  PDB: T:39-106 UniProt: 71-138                             -----------------------------------------------------------Exon 1.6  PDB: T:166-210 UniProt: 198-251     Transcript 1 (1)
           Transcript 1 (2) -Exon 1.3  PDB: T:2-39 UniProt: 34-71  ------------------------------------------------------------------Exon 1.5b  PDB: T:106-165 UniProt: 138-197                  --------------------------------------------- Transcript 1 (2)
                1j9c T    1 SGTTNTVAAYNLTWKSTNFKTILEWEPKPVNQVYTVQISTKSGDWKSKCFYTTDTECDLTDEIVKDVKQTYLARVFSYPAGNVESTGSAGEPLYENSPEFTPYLETNLGQPTIQSFEQVGTKVNVTVEDERTLVRRNNTFLSLRDVFGKDLIYTLYYWKSSSSGKKTAKTNTNEFLIDVDKGENYCFSVQAVIPSRTVNRKSTDSPVECM  210
                                    10        20        30        40        50        60        70        80        90       100       110       120       130       140       150       160       170       180       190       200       210

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (3, 5)

CATH Domains (3, 6)

Pfam Domains (0, 0)

Gene Ontology (61, 72)

Asymmetric/Biological Unit(hide GO term definitions)

Chain H,L (FA7_HUMAN | P08709)

molecular function
	GO:0005509	calcium ion binding	Interacting selectively and non-covalently with calcium ions (Ca2+).
	GO:0004175	endopeptidase activity	Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain.
	GO:0016787	hydrolase activity	Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
	GO:0008233	peptidase activity	Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0005102	receptor binding	Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
	GO:0004252	serine-type endopeptidase activity	Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
	GO:0008236	serine-type peptidase activity	Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
biological process
	GO:0006888	ER to Golgi vesicle-mediated transport	The directed movement of substances from the endoplasmic reticulum (ER) to the Golgi, mediated by COP II vesicles. Small COP II coated vesicles form from the ER and then fuse directly with the cis-Golgi. Larger structures are transported along microtubules to the cis-Golgi.
	GO:0031100	animal organ regeneration	The regrowth of a lost or destroyed animal organ.
	GO:0007596	blood coagulation	The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
	GO:0007598	blood coagulation, extrinsic pathway	A protein activation cascade that contributes to blood coagulation and consists of the self-limited process linking exposure and activation of tissue factor to the activation of clotting factor X.
	GO:0007623	circadian rhythm	Any biological process in an organism that recurs with a regularity of approximately 24 hours.
	GO:0007599	hemostasis	The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
	GO:0017187	peptidyl-glutamic acid carboxylation	The gamma-carboxylation of peptidyl-glutamic acid; catalyzed by the vitamin K dependent gamma-glutamyl carboxylase.
	GO:0030194	positive regulation of blood coagulation	Any process that activates or increases the frequency, rate or extent of blood coagulation.
	GO:0030335	positive regulation of cell migration	Any process that activates or increases the frequency, rate or extent of cell migration.
	GO:0002690	positive regulation of leukocyte chemotaxis	Any process that activates or increases the frequency, rate, or extent of leukocyte chemotaxis.
	GO:0010641	positive regulation of platelet-derived growth factor receptor signaling pathway	Any process that increases the frequency, rate or extent of the platelet-derived growth factor receptor signaling pathway.
	GO:0050927	positive regulation of positive chemotaxis	Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
	GO:0051897	positive regulation of protein kinase B signaling	Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
	GO:0006508	proteolysis	The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
	GO:0043627	response to estrogen	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
	GO:0060416	response to growth hormone	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone stimulus. Growth hormone is a peptide hormone that binds to the growth hormone receptor and stimulates growth.
	GO:0009725	response to hormone	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hormone stimulus.
	GO:0031667	response to nutrient levels	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients.
	GO:0014070	response to organic cyclic compound	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
	GO:0032571	response to vitamin K	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin K stimulus.
	GO:0006465	signal peptide processing	The proteolytic removal of a signal peptide from a protein during or after transport to a specific location in the cell.
cellular component
	GO:0005796	Golgi lumen	The volume enclosed by the membranes of any cisterna or subcompartment of the Golgi apparatus, including the cis- and trans-Golgi networks.
	GO:0005788	endoplasmic reticulum lumen	The volume enclosed by the membranes of the endoplasmic reticulum.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
	GO:0031982	vesicle	Any small, fluid-filled, spherical organelle enclosed by membrane.

Chain T (TF_HUMAN | P13726)

molecular function
	GO:0004896	cytokine receptor activity	Combining with a cytokine and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
	GO:0005543	phospholipid binding	Interacting selectively and non-covalently with phospholipids, a class of lipids containing phosphoric acid as a mono- or diester.
	GO:0002020	protease binding	Interacting selectively and non-covalently with any protease or peptidase.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
biological process
	GO:0002543	activation of blood coagulation via clotting cascade	Any process that initiates the clotting cascade of blood coagulation, a cascade of plasma enzymes that is triggered following damage to blood vessels, leading to formation of a clot.
	GO:0006919	activation of cysteine-type endopeptidase activity involved in apoptotic process	Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process.
	GO:0002541	activation of plasma proteins involved in acute inflammatory response	Any process activating plasma proteins by proteolysis as part of an acute inflammatory response.
	GO:0007568	aging	A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
	GO:0007596	blood coagulation	The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
	GO:0007598	blood coagulation, extrinsic pathway	A protein activation cascade that contributes to blood coagulation and consists of the self-limited process linking exposure and activation of tissue factor to the activation of clotting factor X.
	GO:0070301	cellular response to hydrogen peroxide	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
	GO:0019221	cytokine-mediated signaling pathway	A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
	GO:0007599	hemostasis	The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
	GO:0045766	positive regulation of angiogenesis	Any process that activates or increases angiogenesis.
	GO:0030335	positive regulation of cell migration	Any process that activates or increases the frequency, rate or extent of cell migration.
	GO:0001938	positive regulation of endothelial cell proliferation	Any process that activates or increases the rate or extent of endothelial cell proliferation.
	GO:0010641	positive regulation of platelet-derived growth factor receptor signaling pathway	Any process that increases the frequency, rate or extent of the platelet-derived growth factor receptor signaling pathway.
	GO:0050927	positive regulation of positive chemotaxis	Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
	GO:0051897	positive regulation of protein kinase B signaling	Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
	GO:0014911	positive regulation of smooth muscle cell migration	Any process that activates, maintains or increases the frequency, rate or extent of smooth muscle cell migration.
	GO:0032355	response to estradiol	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
	GO:0034405	response to fluid shear stress	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fluid shear stress stimulus. Fluid shear stress is the force acting on an object in a system where the fluid is moving across a solid surface.
	GO:0032496	response to lipopolysaccharide	Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
	GO:0055098	response to low-density lipoprotein particle stimulus	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a low-density lipoprotein particle stimulus.
	GO:0009612	response to mechanical stimulus	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
	GO:0009266	response to temperature stimulus	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a temperature stimulus.
	GO:0009611	response to wounding	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism.
cellular component
	GO:0009986	cell surface	The external part of the cell wall and/or plasma membrane.
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0031012	extracellular matrix	A structure lying external to one or more cells, which provides structural support for cells or tissues.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0016021	integral component of membrane	The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0031233	intrinsic component of external side of plasma membrane	The component of a plasma membrane consisting of gene products and protein complexes that penetrate the external side of the plasma membrane only, either directly or via some covalently attached hydrophobic anchor.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (5, 5)

Sites (5, 5)

SS Bonds (13, 13)

Cis Peptide Bonds (2, 2)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (106, 106)

PROSITE Motifs (7, 7)

Exons (10, 11)

Sequences/Alignments

Classification and Annotation

SCOP Domains (3, 5)

CATH Domains (3, 6)

Pfam Domains (0, 0)

Gene Ontology (61, 72)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File